Cilomilast
-
Catalog numberB2182-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_namecis-4-Cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid; SB 207499, SB-207499; Ariflo
-
DescriptionCilomilast is an orally active, second-generation phosphodiesterase (PDE) inhibitor that may be effective in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It has high selectivity for the cyclic AMP-specific, or PDE4, isoenzyme that predominates in pro-inflammatory and immune cells and is ten-fold more selective for PDE4D than for PDE4A, B and C.
-
CAS Number153259-65-5
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₀H₂₅NO₄
-
Molecular Weight343.42
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~15 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA PDE4 inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID151170
-
SMILESCOC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3
-
InChiInChI=1S/C20H25NO4/c1-24-17-7-6-15(12-18(17)25-16-4-2-3-5-16)20(13-21)10-8-14(9-11-20)19(22)23/h6-7,12,14,16H,2-5,8-11H2,1H3,(H,22,23)
-
InChi KeyCFBUZOUXXHZCFB-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCilomilast
-
Alternative nameCilomilast
-